Diet, urate, and Parkinson's disease risk in men - PubMed (original) (raw)
Diet, urate, and Parkinson's disease risk in men
Xiang Gao et al. Am J Epidemiol. 2008.
Abstract
The authors examined whether a diet that increases plasma urate level is also related to reduced risk of Parkinson's disease (PD). The study population comprised 47,406 men in the Health Professionals Follow-up Study. The potential effect of diet on plasma urate level was estimated by regressing plasma urate on intakes of selected foods and nutrients in a subsample of 1,387 men. Coefficients of this regression model were then used to calculate a dietary urate index for all cohort participants. Multivariate relative risks of PD were estimated by means of Cox proportional hazards models. After 14 years of follow-up (1986-2000), the authors documented 248 incident cases of PD. A higher dietary urate index was associated with a lower risk of PD (top quintile vs. bottom: relative risk = 0.47, p-trend = 0.0008), after adjustment for age, smoking, caffeine intake, and other potential confounders. This association remained strong and significant after further adjustment for each component of the index individually (p-trend < 0.02 for each). These data support urate as a potentially protective factor in PD and suggest that dietary changes expected to increase plasma urate level may contribute to lower risk of PD. These potential benefits, however, should be weighed against expected adverse effects on risk of gout and other chronic diseases.
Figures
FIGURE 1
Relative risk (RR) of Parkinson’s disease according to quintile (Q) of baseline dietary urate index in the Health Professionals Follow-up Study, 1986-2000. Results were adjusted for age (in months), smoking status (never smoker, past smoker, or current smoker of 1-14 cigarettes/day or ≥15 cigarettes/day), body mass index (weight (kg)/height (m)2; <23, 23-24.9, 25-26.9, 27-29.9, or ≥30), use of nonsteroidal antiinflammatory drugs (yes/no), use of diuretics (yes/no), physical activity (quintiles), caloric intake (kcal/day), and caffeine intake (quintiles). p for trend = 0.0008. Bars, 95% confidence interval.
Similar articles
- Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.
Cipriani S, Chen X, Schwarzschild MA. Cipriani S, et al. Biomark Med. 2010 Oct;4(5):701-12. doi: 10.2217/bmm.10.94. Biomark Med. 2010. PMID: 20945982 Free PMC article. Review. - Urate and the risk of Parkinson's disease in men and women.
Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K. Cortese M, et al. Parkinsonism Relat Disord. 2018 Jul;52:76-82. doi: 10.1016/j.parkreldis.2018.03.026. Epub 2018 Mar 28. Parkinsonism Relat Disord. 2018. PMID: 29615298 - Plasma urate and risk of Parkinson's disease.
Weisskopf MG, O'Reilly E, Chen H, Schwarzschild MA, Ascherio A. Weisskopf MG, et al. Am J Epidemiol. 2007 Sep 1;166(5):561-7. doi: 10.1093/aje/kwm127. Epub 2007 Jun 20. Am J Epidemiol. 2007. PMID: 17584757 Free PMC article. - Prospective study of plasma urate and risk of Parkinson disease in men and women.
Gao X, O'Reilly ÉJ, Schwarzschild MA, Ascherio A. Gao X, et al. Neurology. 2016 Feb 9;86(6):520-6. doi: 10.1212/WNL.0000000000002351. Epub 2016 Jan 13. Neurology. 2016. PMID: 26764029 Free PMC article. - Urate as a marker of development and progression in Parkinson's disease.
Constantinescu R, Zetterberg H. Constantinescu R, et al. Drugs Today (Barc). 2011 May;47(5):369-80. doi: 10.1358/dot.2011.47.5.1591834. Drugs Today (Barc). 2011. PMID: 22013567 Review.
Cited by
- Urate as a predictor of the rate of clinical decline in Parkinson disease.
Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, Oakes D, Fahn S, Shoulson I, Schwarzschild MA; Parkinson Study Group DATATOP Investigators. Ascherio A, et al. Arch Neurol. 2009 Dec;66(12):1460-8. doi: 10.1001/archneurol.2009.247. Arch Neurol. 2009. PMID: 19822770 Free PMC article. Clinical Trial. - Alcohol consumption and probable rapid eye movement sleep behavior disorder.
Ma C, Pavlova M, Li J, Liu Y, Sun Y, Huang Z, Wu S, Gao X. Ma C, et al. Ann Clin Transl Neurol. 2018 Aug 18;5(10):1176-1183. doi: 10.1002/acn3.630. eCollection 2018 Oct. Ann Clin Transl Neurol. 2018. PMID: 30349852 Free PMC article. - Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.
Cipriani S, Chen X, Schwarzschild MA. Cipriani S, et al. Biomark Med. 2010 Oct;4(5):701-12. doi: 10.2217/bmm.10.94. Biomark Med. 2010. PMID: 20945982 Free PMC article. Review. - Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson's Disease.
Franco R, Rivas-Santisteban R, Reyes-Resina I, Navarro G, Martínez-Pinilla E. Franco R, et al. Front Aging Neurosci. 2020 Mar 12;12:12. doi: 10.3389/fnagi.2020.00012. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32226375 Free PMC article. - Intake of antioxidant vitamins and risk of Parkinson's disease.
Hughes KC, Gao X, Kim IY, Rimm EB, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A. Hughes KC, et al. Mov Disord. 2016 Dec;31(12):1909-1914. doi: 10.1002/mds.26819. Epub 2016 Oct 27. Mov Disord. 2016. PMID: 27787934 Free PMC article.
References
- Jenner P. Oxidative stress in Parkinson’s disease. Ann Neurol. 2003;53(suppl 3):S26–36. - PubMed
- de Lau LM, Koudstaal PJ, Hofman A, et al. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005;58:797–800. - PubMed
- Davis JS, Grandinetti A, Waslien CI, et al. Observations on serum uric acid and the risk of idiopathic Parkinson’s disease. Am J Epidemiol. 1996;144:480–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS048517/NS/NINDS NIH HHS/United States
- R01 NS048517-01A2/NS/NINDS NIH HHS/United States
- R01 NS048517-03/NS/NINDS NIH HHS/United States
- Z01 ES101986-02/ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical